Page last updated: 2024-10-25

citalopram and Craniopharyngioma, Adamantinous

citalopram has been researched along with Craniopharyngioma, Adamantinous in 1 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"Citalopram was very well tolerated in these patients and preliminary data are presented that support its efficacy as an antidepressant agent in these patients."1.34Citalopram to treat depression in pediatric oncology. ( DeJong, M; Fombonne, E, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeJong, M1
Fombonne, E1

Other Studies

1 other study available for citalopram and Craniopharyngioma, Adamantinous

ArticleYear
Citalopram to treat depression in pediatric oncology.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:3

    Topics: Adolescent; Central Nervous System Neoplasms; Child; Citalopram; Craniopharyngioma; Depressive Disor

2007